Literature DB >> 27443788

Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells.

Thomas Klonisch1,2,3, Aleksandra Glogowska1, Thatchawan Thanasupawat1, Maxwell Burg1, Jerry Krcek1,2, Marshall Pitz4, Appalaraju Jaggupilli5, Prashen Chelikani5, G William Wong6, Sabine Hombach-Klonisch1,7.   

Abstract

We established the role of the GPCR relaxin/insulin-like family peptide receptor 1 (RXFP1 receptor) as a novel active receptor in human glioblastoma (GB), a fatal brain tumour. We identified C1q/TNF-related protein 8 (CTRP8) as a novel agonist of the RXFP1 receptor. CTRP8 enhanced the motility and matrix invasion of GB, and this involved PKC-mediated up-regulation of cathepsin B, a marker for poor prognosis in GB patients. We conclude that the absence of relaxin isoforms does not preclude the activation of the RXFP1 receptor, as the least known member of the CTRP family, CTRP8, can effectively target and activate RXFP1 receptors. LINKED ARTICLES: This article is part of a themed section on Recent Progress in the Understanding of Relaxin Family Peptides and their Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.10/issuetoc.
© 2016 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27443788      PMCID: PMC5406291          DOI: 10.1111/bph.13559

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  64 in total

Review 1.  An intracellular role for the C1q-globular domain.

Authors:  Giulio Innamorati; Elisabetta Bianchi; Michael Insuk Whang
Journal:  Cell Signal       Date:  2006-01-04       Impact factor: 4.315

2.  Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells.

Authors:  Joanna Bialek; Usakorn Kunanuvat; Sabine Hombach-Klonisch; Antje Spens; Joerg Stetefeld; Kevin Sunley; Dustin Lippert; John A Wilkins; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Mol Cancer Res       Date:  2011-04-14       Impact factor: 5.852

3.  Activation of relaxin-related receptors by short, linear peptides derived from a collagen-containing precursor.

Authors:  Ronen Shemesh; Chen Hermesh; Amir Toporik; Zurit Levine; Amit Novik; Assaf Wool; Yossef Kliger; Avi Rosenberg; Ross A D Bathgate; Yossi Cohen
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

4.  Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.

Authors:  Qi Xu; Arindam Chakravorty; Ross A D Bathgate; Anthony M Dart; Xiao-Jun Du
Journal:  Hypertension       Date:  2010-03-29       Impact factor: 10.190

5.  GIP, a G-protein-coupled receptor interacting protein.

Authors:  Giulio Innamorati; Michael Insuk Whang; Raffaella Molteni; Christian Le Gouill; Mariel Birnbaumer
Journal:  Regul Pept       Date:  2002-11-15

6.  Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch-1 pathway.

Authors:  Giulia Boccalini; Chiara Sassoli; Lucia Formigli; Daniele Bani; Silvia Nistri
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

Review 7.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions.

Authors:  G William Wong; Sarah A Krawczyk; Claire Kitidis-Mitrokostas; Tracy Revett; Ruth Gimeno; Harvey F Lodish
Journal:  Biochem J       Date:  2008-12-01       Impact factor: 3.857

Review 9.  Adiponectin: systemic contributor to insulin sensitivity.

Authors:  Utpal B Pajvani; Philipp E Scherer
Journal:  Curr Diab Rep       Date:  2003-06       Impact factor: 4.810

Review 10.  Long-term survival with glioblastoma multiforme.

Authors:  Dietmar Krex; Barbara Klink; Christian Hartmann; Andreas von Deimling; Torsten Pietsch; Matthias Simon; Michael Sabel; Joachim P Steinbach; Oliver Heese; Guido Reifenberger; Michael Weller; Gabriele Schackert
Journal:  Brain       Date:  2007-09-04       Impact factor: 13.501

View more
  9 in total

1.  Recent progress in the understanding of relaxin family peptides and their receptors.

Authors:  R J Summers
Journal:  Br J Pharmacol       Date:  2017-05       Impact factor: 8.739

Review 2.  C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation.

Authors:  Ying Li; Gary L Wright; Jonathan M Peterson
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

3.  An adiponectin paralog protein, CTRP6 decreased the proliferation and invasion activity of oral squamous cell carcinoma cells: possible interaction with laminin receptor pathway.

Authors:  Kimika Hano; Kiichi Hatano; Chiemi Saigo; Yusuke Kito; Toshiyuki Shibata; Tamotsu Takeuchi
Journal:  Mol Biol Rep       Date:  2019-06-28       Impact factor: 2.316

4.  Global gene expression profiles of hematopoietic stem and progenitor cells from patients with chronic myeloid leukemia: the effect of in vitro culture with or without imatinib.

Authors:  Sócrates Avilés-Vázquez; Antonieta Chávez-González; Alfredo Hidalgo-Miranda; Dafne Moreno-Lorenzana; Lourdes Arriaga-Pizano; Miguel Á Sandoval-Esquivel; Manuel Ayala-Sánchez; Rafael Aguilar; Luis Alfaro-Ruiz; Hector Mayani
Journal:  Cancer Med       Date:  2017-10-13       Impact factor: 4.452

5.  Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma.

Authors:  Liyan Chen; Gang Su
Journal:  Biomed Res Int       Date:  2019-04-30       Impact factor: 3.411

6.  C1QTNF6 promotes oral squamous cell carcinoma by enhancing proliferation and inhibiting apoptosis.

Authors:  Xiaobin Song; Longjie Li; Liang Shi; Xinyu Liu; Xun Qu; Fengcai Wei; Ketao Wang
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

Review 7.  Novel insights into the pathological mechanisms of metabolic related dyslipidemia.

Authors:  Xin Su; Ye Cheng; Guoming Zhang; Bin Wang
Journal:  Mol Biol Rep       Date:  2021-07-04       Impact factor: 2.316

8.  A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.

Authors:  Hui Xie; Conghua Xie
Journal:  Biomed Res Int       Date:  2019-12-04       Impact factor: 3.411

Review 9.  Complement's favourite organelle-Mitochondria?

Authors:  Jubayer Rahman; Parul Singh; Nicolas S Merle; Nathalie Niyonzima; Claudia Kemper
Journal:  Br J Pharmacol       Date:  2020-09-28       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.